Literature DB >> 29778207

Evolution in Europe of African swine fever genotype II viruses from highly to moderately virulent.

Gallardo C1, Nurmoja I2, Soler A3, Delicado V3, Simón A3, Martin E3, Perez C3, Nieto R3, Arias M3.   

Abstract

Since its arrival in the Caucasus and Russia in 2007, African swine fever virus (ASFV) has spread widely and has now affected the EU countries of Estonia, Latvia, Lithuania, Poland and, more recently, the Czech Republic and Romania. The ever-increasing evidence of seropositive wild boar in certain areas suggests that some animals may be surviving for some time or could even be recovering from the disease. This could be due to acquired immunity after the primary infection and/or the presence of related viruses of reduced virulence. To assess these hypotheses, two ASFV field strains from Estonia were studied in vivo in two groups of domestic pigs. After an incubation period of 4 ± 1.6 days, the pigs inoculated intramuscularly with Es15/WB-Tartu 14 ASFV (group 2) developed clinical signs associated with acute disease and succumbed 7 and 11 days post infection (dpi). Pigs inoculated with Es15/WB-Valga-14 ASFV (group 1) had longer incubation times (8 days) than those in group 2 and developed variable clinical signs and lesions compatible with subacute and chronic forms of ASF; they succumbed at 11 and 25 dpi. The in-contact pigs in both groups became infected 7-14 days after exposure and exhibited variable clinical manifestations and pathological findings ranging from acute to chronic disease. Two animals per group recovered completely after infection and were protected against a subsequent homologous virus challenge-exposure performed at 78 dpi. Under experimental conditions, no transmission occurred from the survivors to susceptible sentinel pigs housed together with the survivors 137 days after the primary infection.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  African swine fever; Genotype II; Moderate virulence

Mesh:

Year:  2018        PMID: 29778207     DOI: 10.1016/j.vetmic.2018.04.001

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  25 in total

1.  ASF Exit Strategy: Providing cumulative evidence of the absence of African swine fever virus circulation in wild boar populations using standard surveillance measures.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; Jose Luis Gonzales Rojas; Christian Gortazar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Stahl; Antonio Velarde; Christoph Winckler; José Cortiňas Abrahantes; Sofie Dhollander; Corina Ivanciu; Alexandra Papanikolaou; Yves Van der Stede; Sandra Blome; Vittorio Guberti; Federica Loi; Simon More; Edvins Olsevskis; Hans Hermann Thulke; Arvo Viltrop
Journal:  EFSA J       Date:  2021-03-03

2.  Scientific Opinion on the assessment of the control measures of the category A diseases of Animal Health Law: African Swine Fever.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Klaus Depner; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar Schmidt; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Paolo Pasquali; Helen Clare Roberts; Liisa Helena Sihvonen; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Kris De Clercq; Eyal Klement; Jan Arend Stegeman; Simon Gubbins; Sotiria-Eleni Antoniou; Alessandro Broglia; Yves Van der Stede; Gabriele Zancanaro; Inma Aznar
Journal:  EFSA J       Date:  2021-01-31

3.  Possibility of long-term survival of African swine fever virus in natural conditions.

Authors:  Hranush Arzumanyan; Sona Hakobyan; Hranush Avagyan; Roza Izmailyan; Narek Nersisyan; Zaven Karalyan
Journal:  Vet World       Date:  2021-04-09

Review 4.  African Swine Fever: Fast and Furious or Slow and Steady?

Authors:  Katja Schulz; Franz Josef Conraths; Sandra Blome; Christoph Staubach; Carola Sauter-Louis
Journal:  Viruses       Date:  2019-09-17       Impact factor: 5.048

5.  The first genotype II African swine fever virus isolated in Africa provides insight into the current Eurasian pandemic.

Authors:  Emma P Njau; Jean-Baka Domelevo Entfellner; Eunice M Machuka; Edwina N Bochere; Sarah Cleaveland; Gabriel M Shirima; Lughano J Kusiluka; Chris Upton; Richard P Bishop; Roger Pelle; Edward A Okoth
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

6.  Evaluation of Lesions and Viral Antigen Distribution in Domestic Pigs Inoculated Intranasally with African Swine Fever Virus Ken05/Tk1 (Genotype X).

Authors:  Pedro J Sánchez-Cordón; Tobias Floyd; Daniel Hicks; Helen R Crooke; Stephen McCleary; Ronan R McCarthy; Rebecca Strong; Linda K Dixon; Aleksija Neimanis; Emil Wikström-Lassa; Dolores Gavier-Widén; Alejandro Núñez
Journal:  Pathogens       Date:  2021-06-18

Review 7.  African Swine Fever: Disease Dynamics in Wild Boar Experimentally Infected with ASFV Isolates Belonging to Genotype I and II.

Authors:  Pedro J Sánchez-Cordón; Alejandro Nunez; Aleksija Neimanis; Emil Wikström-Lassa; María Montoya; Helen Crooke; Dolores Gavier-Widén
Journal:  Viruses       Date:  2019-09-13       Impact factor: 5.048

8.  Evolution of the ASF Infection Stage in Wild Boar Within the EU (2014-2018).

Authors:  Marta Martínez-Avilés; Irene Iglesias; Ana De La Torre
Journal:  Front Vet Sci       Date:  2020-04-01

9.  Serum-Derived Extracellular Vesicles from African Swine Fever Virus-Infected Pigs Selectively Recruit Viral and Porcine Proteins.

Authors:  Sergio Montaner-Tarbes; Myriam Pujol; Tamara Jabbar; Philippa Hawes; Dave Chapman; Hernando Del Portillo; Lorenzo Fraile; Pedro J Sánchez-Cordón; Linda Dixon; Maria Montoya
Journal:  Viruses       Date:  2019-09-20       Impact factor: 5.048

10.  The recombinant pseudorabies virus expressing African swine fever virus CD2v protein is safe and effective in mice.

Authors:  Zhihua Feng; Jianghua Chen; Wangwang Liang; Wenzhi Chen; Zhaolong Li; Qi Chen; Shaoli Cai
Journal:  Virol J       Date:  2020-11-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.